Universal American downgraded to Sell from Neutral at Goldman Goldman downgraded Universal American to reflect Medicare Advantage risk given scheduled funding reductions. Price target is $8.
News For UAM From The Last 14 Days
Check below for free stories on UAM the last two weeks.